/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

C

Christine M. Bestvina

University of Chicago Medicine Comprehensive Cancer Center

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

261

Papers

3.9K

Citations

20

h-index

31

i10-index

Christine M. Bestvina is an academic researcher from University of Chicago Medicine Comprehensive Cancer Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Colorectal Cancer Treatments and Studies & Genetic factors in colorectal cancer. The author has an h-index of 20, co-authored 222 publications.

ORCID: 0000-0001-7189-1590

Research Topics

Lung Cancer Treatments and Mutations Colorectal Cancer Treatments and Studies Genetic factors in colorectal cancer Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies

Papers by this author

works

Patient-Oncologist Cost Communication, Financial Distress, and Medication Adherence

2014 · Journal of Oncology Practice · 255 citations

https://doi.org/10.1200/jop.2014.001406

Christine M. Bestvina Leah L. Zullig Christel Rushing Fumiko Chino

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

2024 · Nature · 123 citations

https://doi.org/10.1038/s41586-024-07943-7

Ferdinandos Skoulidis Haniel A. Araújo Minh Truong Yu Qian

Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC

2024 · Journal of Thoracic Oncology · 63 citations

https://doi.org/10.1016/j.jtho.2024.03.010

Jacobi Hines Robert B. Cameron A. Esposito Leeseul Kim

The Role of MET in Resistance to EGFR Inhibition in NSCLC: A Review of Mechanisms and Treatment Implications

2023 · Cancers · 26 citations

https://doi.org/10.3390/cancers15112998

Susan Feldt Christine M. Bestvina

The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project

2024 · Cancer Medicine · 9 citations

https://doi.org/10.1002/cam4.7159

Valeria Sebri Chiara Marzorati Patrizia Dorangricchia Dario Monzani

A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors

2023 · JTO Clinical and Research Reports · 5 citations

https://doi.org/10.1016/j.jtocrr.2023.100619

Kathryn E. Beckermann Christine M. Bestvina Badi El Osta Rachel E. Sanborn

Research topics

topics

Lung Cancer Treatments and Mutations

Colorectal Cancer Treatments and Studies

Genetic factors in colorectal cancer

Cancer Immunotherapy and Biomarkers

Lung Cancer Research Studies

Chat about Author

Papers

Chat

Click to start Chat